Vaso Healthcare, a Subsidiary of Vasomedical, Inc. Announces Extension of Exclusive Sales Representative Agreement with GE

  Vaso Healthcare, a Subsidiary of Vasomedical, Inc. Announces Extension of
  Exclusive Sales Representative Agreement with GE Healthcare

Business Wire

WESTBURY, N.Y. -- June 25, 2012

Vasomedical, Inc. a diversified medical technology company specializing in the
design, manufacture and sale of medical devices and in the domestic sale of
diagnostic imaging products, today announces the amendment of the sales
representative agreement between its subsidiary, Vaso Diagnostics Inc. d/b/a
Vaso Healthcare and GE Healthcare, the healthcare business unit of GE (NYSE:
GE), originally signed on May 19, 2010.

The amendment, effective July 1, 2012, extends the initial term of three years
commencing July 1, 2010 to five years through June 30, 2015, subject to
earlier termination under certain circumstances. Under the agreement,
VasoHealthcare is the exclusive representative for the sale of select GE
Healthcare Diagnostic Imaging products to specific market segments in the 48
contiguous states of the United States and the District of Columbia.

“The extension of the agreement is verification of the professionalism,
dedication and performance of our VasoHealthcare sales team” commented Jun Ma,
President and CEO of Vasomedical, Inc. “The start of the sales representation
business two years ago is part of the diversification strategy of the company,
which also includes our expanded international operations and new product
lines. We continue to look for accretive acquisitions as well as other related
opportunities in the medical device business, with the objective of enhancing
our business and increasing shareholder value.”

About Vasomedical

Vasomedical, Inc. is a diversified medical technology company specializing in
the manufacture and sale of medical devices and in the domestic sale of
diagnostic imaging products. The Company operates through three wholly-owned
subsidiaries. Vasomedical Solutions manages and coordinates the design,
manufacture and sales of EECP^®therapy systems, its core product, as well as
other medical equipment operations; Vasomedical Global operates the Company’s
China-based subsidiaries; and Vaso Diagnostics, d/b/a VasoHealthcare, is the
operating subsidiary for the sales representation of GE Healthcare diagnostic
imaging products. Additional information is available on the Company's website
atwww.vasomedical.com.

Except for historical information contained in this release, the matters
discussed are forward-looking statements that involve risks and uncertainties.
When used in this release, words such as “anticipates”, “believes”, “could”,
“estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar
expressions, as they relate to the Company or its management, identify
forward-looking statements. Such forward-looking statements are based on the
beliefs of the Company’s management, as well as assumptions made by and
information currently available to the Company’s management. Among the factors
that could cause actual results to differ materially are the following: the
effect of business and economic conditions; the effect of the dramatic changes
taking place in the healthcare environment; the impact of competitive
procedures and products and their pricing; medical insurance reimbursement
policies; unexpected manufacturing or supplier problems; unforeseen
difficulties and delays in the conduct of clinical trials and other product
development programs; the actions of regulatory authorities and third-party
payers in the United States and overseas; uncertainties about the acceptance
of a novel therapeutic modality by the medical community; continuation of the
GEHC agreement; and the risk factors reported from time to time in the
Company’s SEC reports.The Company undertakes no obligation to update
forward-looking statements as a result of future events or developments.

Contact:

Vasomedical, Inc.
Investor Relations:
Dr. Jun Ma, 516-997-4600
President and CEO
customerservice@vasomedical.com
or
Michael Beecher, 516-997-4600
CFO
 
Press spacebar to pause and continue. Press esc to stop.